Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard

Magnetic Resonance Imaging(2023)10.1016/j.mri.2023.01.006Source: DataRank Database

Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard is a research paper published in Magnetic Resonance Imaging (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: hybridTopics (68)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Jeffry Simko,Peter R. Carroll ORCID,Susan M. Noworolski ORCID,Matthew Gibbons ORCID

Live enrichment

PubMed:36641104 PMC:PMC11229728

NCI NIH HHS

Grant: R01 CA148708

National Institutes of Health

Grant: 1R01CA148708-01

DCE MRI to Improve Prostate Cancer Identification and Characterization

hybridLicense: CC BY

publisherhttps://api.elsevier.com/content/article/PII:S0730725X23000073?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0730725X23000073?httpAccept=text/plain

Europe_PMChttps://europepmc.org/articles/PMC11229728

Europe_PMChttps://europepmc.org/articles/PMC11229728?pdf=render

https://doi.org/10.1016/j.mri.2023.01.006

Fields of Study

0302 clinical medicine03 medical and health sciences

MeSH Terms

ProstateHumansProstatic NeoplasmsMagnetic Resonance ImagingDiffusion Magnetic Resonance ImagingRetrospective StudiesReference StandardsMaleMultiparametric Magnetic Resonance Imaging

Keywords

Histopathologyprostate cancerDiffusion-weighted ImagingDynamic Contrast-enhanced ImagingMultiparametric MriPrevention (rcdc)Magnetic Resonance Imaging (mesh)MaleAgingProstate Cancer (rcdc)Aging (rcdc)Biomedical Imaging (rcdc)Diffusion -weighted imaging1103 Clinical Sciences (for)Reference Standards (mesh)32 Biomedical and Clinical Sciences (for-2020)Male (mesh)Dynamic contrast -enhanced imagingCancerCancer (rcdc)Humans (mesh)Bioengineering (rcdc)Prostate600Reference StandardsMagnetic Resonance ImagingNuclear Medicine & Medical Imaging (science-metrix)Nuclear Medicine & Medical ImagingMultiparametric Magnetic Resonance Imaging (mesh)Biomedical ImagingCognitive SciencesProstatic Neoplasms (mesh)Urologic DiseasesDiffusion Magnetic Resonance Imaging (mesh)Retrospective Studies (mesh)Clinical SciencesOncology and CarcinogenesisBiomedical Engineering610BioengineeringArticle0903 Biomedical Engineering (for)HumansMultiparametric Magnetic Resonance Imaging3202 Clinical Sciences (for-2020)Retrospective StudiesBiomedical and Clinical SciencesPrevention4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac)Prostatic NeoplasmsCancer (hrcs-hc)Prostate (mesh)4.1 Discovery and preclinical testing of markers and technologies3211 Oncology and Carcinogenesis (for-2020)Diffusion Magnetic Resonance ImagingUrologic Diseases (rcdc)1702 Cognitive Sciences (for)